The ACTA Trial of the Year Awards were established in 2016 and has been traditionally celebrated in International Clinical Trials day in May, as part of a National Tribute and Awards Ceremony. In 2020, the awards were delayed due to COVID-19, and are instead being presented as part of the opening of the Summit.
The awards honour the remarkable Australians who advance our health system by designing, conducting or participating in ground-breaking clinical trials, and promote the importance of clinical trials and the expertise and complexity of work involved. Trials considered for the award are collaboratively developed, multicentre, investigator-driven randomised controlled trials that were designed to improve patient-centred outcomes or healthcare delivery.
In 2020, eleven applications were received for the main Trial of the Year Award, as below. There are currently three main awards and we aim to add further awards in 2021, to recognise industry collaboration and clinical quality registries.
The 2020 ACTA Trial of the Year, ACTA STInG Excellence in Trial Statistics Award and the ACTA Consumer Involvement Awards, will be announced at the the ACTA Summit 2020 on 1 December, 2020, and we hope you will join us.
Please register here for the Awards Ceremony and Summit:
Alternatively, you can join the Awards Ceremony directly through live stream (between 10 and 11:40 am on 1 December, 2020):
Latest Resources
Statistical Analysis Plan
ACTA Board Charter
ACTA Constitution
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
ACTA Trial of the Year Award 2020 guidelines and nomination forms
ACTA Year in Review: Financial Year 2018/2019
ACTA Resources Brochure
ACTA activity work plan 2019 – 2020
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
What a trialist should know about implementation to practice
Submission to MRFF Consultation
Submission to Medical Research Future Fund Priority Consultation
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
ACTA Advisory Council minutes July 2017
Economic evaluation of investigator-initiated clinical trials conducted by networks
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
Opportunities for linking evidence development to reimbursement in Australia
Clinical Quality Registries: A national approach
How can clinical trials networks drive better translation of evidence into better quality care?
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
ACTA Summit 2016 – Opening address
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
ACTA Summit 2016 – Dr Neil Soderlund
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
ACTA STInG Submission to the NHMRC Structural Review
ACTA Submission to the NHMRC Structural Review
ACTA Submission on the MRFF Strategy & Priorities
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
ACTA submission on safety monitoring & reporting of clincial trials in Australia
Report on the Activities and Achievements of Clinical Trials Networks in Australia 2004-2014
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
ACTA Submission on draft Principles for accessing and using publicly funded data for health research